Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...
Dean Maglaris, CEO of Cytogel Pharma has announced that Alan W. Dunton, M.D. has been named to the Board of Cytogel.&nbs...
Samsung Electronics is all set to open a new artificial intelligence (AI) research centre in New York City, U.S., to str...
LimaCorporate, a pioneer and leader in a 3D printing of Orthopaedic implants, announces the milestone-based acquisition ...
The Healthcare Businesswomen’s Association (HBA) has announced that twelve prominent healthcare and life science c...
Westlake Village BioPartners, a new venture firm exclusively focused on investing in life sciences has announced the lau...
AGC Biologics, a contract development and manufacturing organization specializing in the clinical and commercial manufac...
Ares Genetics, a division of German molecular diagnostics company Curetis, has initiated the development of a new diagno...
Active Biotech has announced that it regains the global development and commercialization rights to laquinimod from...
Singapore - Agios Pharmaceuticals and Celgene have mutually agreed to terminate their collaboration and ...
Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthr...
Nightingale Health, the Finnish innovator of an internationally recognized blood biomarker technology for studying chron...
Digital medicine platform Rx.Health, a Mount Sinai Health System spinoff and provider of RxUniverse has recently announc...
Merck, the vibrant science and technology company, has launched three new products to help biomanufacturers navigate the...
Singapore - Tabula Rasa HealthCare has acquired Mediture and eClusive, a leading electronic health record solu...
Singapore –Zebra Technologies Corporation, an innovator at the edge of the enterprise with solutions and partners ...
A team of researchers at the University of Texas has developed a new diagnostic tool to identify a species of mosquito t...
The global orphan and rare dermatology premium products market is expected to grow rapidly from $1.64 billion in 2017 to...
